Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385475986> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4385475986 endingPage "131" @default.
- W4385475986 startingPage "123" @default.
- W4385475986 abstract "To conduct a meta-analysis of the diagnostic efficacy of fluorine-18-fluorodeoxyglucose (18F-FDG) and gallium-68-labeled fibroblast-activation protein inhibitor (68Ga-FAPI) positron emission tomography/computed tomography (PET/CT) for primary liver cancer based on existing clinical evidence.Meta-analysis was carried out according to PRISMA reporting specification. The clinical studies in PubMed/Medline, Embase and the Cochrane Library database were retrieved from the establishment to September 2022. Two researchers independently conducted literature screening and data extraction, evaluated the risk of bias according to QUADAS-2, conducted meta-analysis using Meta Disc 1.4 and Stata15.1 software, and calculated the summarized sensitivity (SEN), specificity (SPE), positive likelihood ratio (+LR), negative likelihood ratio (-LR), and diagnostic odds ratio (DOR). The diagnostic performance of 18F-FDG PET/CT and 68Ga-FAPI PET/CT for primary liver cancer was compared using summarized receiver operating characteristic (SROC) curve and area under curve (AUC).Four original studies on 18F-FDG PET/CT and 68Ga-FAPI PET/CT in the diagnosis of primary liver cancer were included, including 159 intrahepatic lesions in 106 patients. Taking lesions as a unit, in four original studies, the pooled results of 18F-FDG PET/CT diagnosis of primary liver cancer were Sen=0.5 (95% CI:95% CI: 0.41-0.59), Spe=0.87 (95% CI: 0.52-0.98), AUC=0.58 (95% CI:0.53-0.62); The pooled results of 68Ga-FAPI PET/CT in the diagnosis of primary liver cancer, Sen=0.5 (95% CI: 0.41-0.59), Spe=0.87 (95%CI:0.52-0.98), AUC=0.58 (95% CI:0.53-0.62). Besides, the Sen of 68Ga-FAPI PET/CT in the diagnosis of primary liver cancer was higher than that of 18F-FDG PET/CT (Z=2.323, P=0.02), the difference was statistically significant.Gallium-68-FAPI PET/CT is a promising tool. Compared with 18F-FDG, 68Ga-FAPI has higher sensitivity to detect more lesions in primary liver cancer and metastatic lesions, and has high performance in the diagnosis of primary liver cancer." @default.
- W4385475986 created "2023-08-03" @default.
- W4385475986 creator A5032278821 @default.
- W4385475986 creator A5044852869 @default.
- W4385475986 creator A5062736289 @default.
- W4385475986 creator A5092786590 @default.
- W4385475986 date "2023-08-01" @default.
- W4385475986 modified "2023-10-16" @default.
- W4385475986 title "Diagnostic value of 18F-FDG PET/CT and 68Ga-FAPI PET/CT in primary liver cancer: A systematic review and meta-analysis." @default.
- W4385475986 doi "https://doi.org/10.1967/s002449912575" @default.
- W4385475986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37527048" @default.
- W4385475986 hasPublicationYear "2023" @default.
- W4385475986 type Work @default.
- W4385475986 citedByCount "0" @default.
- W4385475986 crossrefType "journal-article" @default.
- W4385475986 hasAuthorship W4385475986A5032278821 @default.
- W4385475986 hasAuthorship W4385475986A5044852869 @default.
- W4385475986 hasAuthorship W4385475986A5062736289 @default.
- W4385475986 hasAuthorship W4385475986A5092786590 @default.
- W4385475986 hasConcept C121608353 @default.
- W4385475986 hasConcept C126322002 @default.
- W4385475986 hasConcept C126838900 @default.
- W4385475986 hasConcept C127077266 @default.
- W4385475986 hasConcept C156957248 @default.
- W4385475986 hasConcept C157481446 @default.
- W4385475986 hasConcept C2775842073 @default.
- W4385475986 hasConcept C2776478404 @default.
- W4385475986 hasConcept C2989005 @default.
- W4385475986 hasConcept C58471807 @default.
- W4385475986 hasConcept C71924100 @default.
- W4385475986 hasConcept C95190672 @default.
- W4385475986 hasConceptScore W4385475986C121608353 @default.
- W4385475986 hasConceptScore W4385475986C126322002 @default.
- W4385475986 hasConceptScore W4385475986C126838900 @default.
- W4385475986 hasConceptScore W4385475986C127077266 @default.
- W4385475986 hasConceptScore W4385475986C156957248 @default.
- W4385475986 hasConceptScore W4385475986C157481446 @default.
- W4385475986 hasConceptScore W4385475986C2775842073 @default.
- W4385475986 hasConceptScore W4385475986C2776478404 @default.
- W4385475986 hasConceptScore W4385475986C2989005 @default.
- W4385475986 hasConceptScore W4385475986C58471807 @default.
- W4385475986 hasConceptScore W4385475986C71924100 @default.
- W4385475986 hasConceptScore W4385475986C95190672 @default.
- W4385475986 hasIssue "2" @default.
- W4385475986 hasLocation W43854759861 @default.
- W4385475986 hasOpenAccess W4385475986 @default.
- W4385475986 hasPrimaryLocation W43854759861 @default.
- W4385475986 hasRelatedWork W2348134738 @default.
- W4385475986 hasRelatedWork W2790511401 @default.
- W4385475986 hasRelatedWork W3031517306 @default.
- W4385475986 hasRelatedWork W3111323089 @default.
- W4385475986 hasRelatedWork W3134458896 @default.
- W4385475986 hasRelatedWork W3163989561 @default.
- W4385475986 hasRelatedWork W4226159373 @default.
- W4385475986 hasRelatedWork W4319316009 @default.
- W4385475986 hasRelatedWork W4380591563 @default.
- W4385475986 hasRelatedWork W2028342018 @default.
- W4385475986 hasVolume "26" @default.
- W4385475986 isParatext "false" @default.
- W4385475986 isRetracted "false" @default.
- W4385475986 workType "article" @default.